Spots Global Cancer Trial Database for Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
Official Title: Gadobenate Dimeglumine Compared to Gadobutrol for MRI Perfusion Analysis in Brain Tumor Patients
Study ID: NCT02095353
Conditions
Interventions
Study Description
Brief Summary: This study will compare the use of two contrast agents to analyze blood flow characteristics of brain tumors.
Detailed Description: This study will compare contrast agents, gadobenate dimeglumine and gadobutrol, for MRI perfusion analysis in brain tumor patients.
Eligibility
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States
Contact Details
Name: Matthew White, MD
Affiliation: University of Nebraska
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
